Moolec Science reports FY24 EPS (19c) vs. ($1.50) last year

Teports FY24 revenue $6.12M vs. $940,000 last year.”I am proud of our team of ‘Moolers’ for their relentless dedication and repeated achievement of significant milestones. This fiscal year has been truly transformative for Moolec Science. The groundbreaking USDA-APHIS approval for PiggySooy(TM) marks a pivotal moment in the Molecular Farming and biotech landscape. Coupled with the imminent commercialization of GLASO(TM), for which we’ve already secured commercial agreements, and our robust pipeline progressing on schedule, we’ve demonstrated remarkable progress across all fronts. Our team’s unwavering commitment and innovative spirit have been the driving force behind these accomplishments. As we look to the future, I am filled with optimism about the impending commercialization of our groundbreaking products. We stand at the cusp of revolutionizing the food industry through molecular farming, offering sustainable and cost-effective solutions to global nutritional challenges. The coming years hold immense promise as we continue to push the boundaries of science and redefine the future of food production,” stated Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec.